0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Insulet Corporation - Trending symbols

Latest News of Insulet Corporation

DateTitleRead
2025-06-17
14:45
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue OpportunitiesRead
2025-06-08
15:05
Notable healthcare headlines for the week: Bristol Myers Squibb, Novo Nordisk and Sanofi in focusRead
2025-06-03
17:30
S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETFRead
2025-06-02
21:18
Solventum Stock Earns RS Rating UpgradeRead
2025-05-28
20:01
Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?Read
2025-05-22
15:36
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion TechnologiesRead
2025-05-22
15:18
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pickRead



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Debt 704,600-22,300682,300-186,600495,700-57,000438,700-1,638,700-1,200,000
Retained Earnings -378,00051,500-326,500188,600-137,90077,500-60,400100,70040,300
Net Interest Income -500-800-1,300-400-1,700-100-1,8003,4001,600
Cost of Revenue 139,4009,200148,600-16,800131,80022,500154,300-158,800-4,500
Tax Provision 1,2006001,8002,7004,500-1,1003,400-140,900-137,500
Accumulated Other Comprehensive Income 15,90040016,300-8,7007,6004008,000-8,500-500
Income Tax Expense 5,300-4,5008004001,2006001,800-13,900-12,100
Interest Expense 2,7002002,900-5002,400-6001,800-45,100-43,300
EBITDA 2,40042,80045,20017,40062,600-10,10052,500-64,700-12,200
Operating Income 26,3007,40033,70016,00049,700-11,80037,900-64,600-26,700
Net non Operating Income Other -2,600-35,700-38,30036,100-2,2001,000-1,2001,500300

Comments

How you think about this?

Leave a comment

Stay informed about Insulet Corporation.

Receive notifications about Insulet Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.